The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 Peptide and Lyme Disease: Tissue Repair and Immune Support Peptides may soon be easier to get amid RFK Jr.'s push, but experts warn of risks FDA takes first step in possible reversal of ban on some peptides The Washington Post